v3.26.1
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Operating activities:    
Net (loss) income $ (721) $ 5,630
Adjustments to reconcile net (loss) income to cash used for operating activities:    
Depreciation and amortization 48,899 43,932
Stock-based compensation 2,402 1,825
Deferred income tax 918 1,250
Other, net 3,800 7,243
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable (4,479) 5,322
Increase in inventory (21,719) (1,333)
Increase in other current assets (6,200) (7,828)
Decrease in accounts payable (2,459) (14,771)
Decrease in accrued liabilities (10,411) (14,048)
Change in income taxes (12,005) (5,471)
Other, net 689 (5,764)
Cash (used for) provided by operating activities (1,286) 15,987
Investing activities:    
Capital expenditures (22,322) (26,544)
Proceeds from disposition of capital assets 29 376
Cash used for investing activities (22,293) (26,168)
Financing activities:    
Borrowings under credit facility 119,000 125,000
Repayments of credit facility borrowings (99,500) (117,500)
Repayments of other long-term debt (1,762) (1,888)
Common stock dividends paid (7,277) (7,552)
Purchase of treasury stock 0 (27,194)
Proceeds from (Payment for) Other Financing Activity (696) (1,186)
Cash provided by (used for) financing activities 9,765 (30,320)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,680 2,303
Decrease in cash, cash equivalents and restricted cash (12,134) (38,198)
Cash, cash equivalents and restricted cash at beginning of period 78,118 102,995
Cash, cash equivalents and restricted cash at end of period $ 65,984 $ 64,797